Logo image of NSKOG.OL

NORSKE SKOG ASA (NSKOG.OL) Stock Fundamental Analysis

OSL:NSKOG - Euronext Oslo - NO0010861115 - Common Stock - Currency: NOK

21.9  +0.2 (+0.92%)

Fundamental Rating

3

Taking everything into account, NSKOG scores 3 out of 10 in our fundamental rating. NSKOG was compared to 11 industry peers in the Paper & Forest Products industry. NSKOG may be in some trouble as it scores bad on both profitability and health. NSKOG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NSKOG had positive earnings in the past year.
In the past year NSKOG has reported a negative cash flow from operations.
In multiple years NSKOG reported negative net income over the last 5 years.
In multiple years NSKOG reported negative operating cash flow during the last 5 years.
NSKOG.OL Yearly Net Income VS EBIT VS OCF VS FCFNSKOG.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B

1.2 Ratios

NSKOG's Return On Assets of -1.75% is on the low side compared to the rest of the industry. NSKOG is outperformed by 63.64% of its industry peers.
With a Return On Equity value of -4.46%, NSKOG is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 5.29%, NSKOG is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
NSKOG had an Average Return On Invested Capital over the past 3 years of 7.92%. This is in line with the industry average of 6.81%.
Industry RankSector Rank
ROA -1.75%
ROE -4.46%
ROIC 5.29%
ROA(3y)6.63%
ROA(5y)-1.66%
ROE(3y)15.08%
ROE(5y)-4.97%
ROIC(3y)7.92%
ROIC(5y)5.72%
NSKOG.OL Yearly ROA, ROE, ROICNSKOG.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

The Operating Margin of NSKOG (6.68%) is better than 72.73% of its industry peers.
In the last couple of years the Operating Margin of NSKOG has declined.
NSKOG has a Gross Margin (34.68%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NSKOG has remained more or less at the same level.
Industry RankSector Rank
OM 6.68%
PM (TTM) N/A
GM 34.68%
OM growth 3Y-10.16%
OM growth 5Y-29.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.52%
NSKOG.OL Yearly Profit, Operating, Gross MarginsNSKOG.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, NSKOG has about the same amount of shares outstanding.
The number of shares outstanding for NSKOG has been increased compared to 5 years ago.
The debt/assets ratio for NSKOG is higher compared to a year ago.
NSKOG.OL Yearly Shares OutstandingNSKOG.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NSKOG.OL Yearly Total Debt VS Total AssetsNSKOG.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

NSKOG has an Altman-Z score of 0.79. This is a bad value and indicates that NSKOG is not financially healthy and even has some risk of bankruptcy.
NSKOG's Altman-Z score of 0.79 is on the low side compared to the rest of the industry. NSKOG is outperformed by 72.73% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that NSKOG is somewhat dependend on debt financing.
NSKOG's Debt to Equity ratio of 0.78 is in line compared to the rest of the industry. NSKOG outperforms 45.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACCN/A
WACCN/A
NSKOG.OL Yearly LT Debt VS Equity VS FCFNSKOG.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

NSKOG has a Current Ratio of 1.29. This is a normal value and indicates that NSKOG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.29, NSKOG is in line with its industry, outperforming 45.45% of the companies in the same industry.
NSKOG has a Quick Ratio of 1.29. This is a bad value and indicates that NSKOG is not financially healthy enough and could expect problems in meeting its short term obligations.
NSKOG has a Quick ratio (0.86) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.86
NSKOG.OL Yearly Current Assets VS Current LiabilitesNSKOG.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for NSKOG have decreased strongly by -73.03% in the last year.
The Revenue has decreased by -5.87% in the past year.
The Revenue for NSKOG have been decreasing by -29.57% on average. This is quite bad
EPS 1Y (TTM)-73.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%323.37%
Revenue 1Y (TTM)-5.87%
Revenue growth 3Y-40.12%
Revenue growth 5Y-29.57%
Sales Q2Q%21.56%

3.2 Future

The Earnings Per Share is expected to grow by 26.11% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.17% on average over the next years.
EPS Next Y92.21%
EPS Next 2Y28.05%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue Next Year3.98%
Revenue Next 2Y8.26%
Revenue Next 3Y5.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NSKOG.OL Yearly Revenue VS EstimatesNSKOG.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
NSKOG.OL Yearly EPS VS EstimatesNSKOG.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.00, which indicates a very decent valuation of NSKOG.
Compared to the rest of the industry, the Price/Earnings ratio of NSKOG is on the same level as its industry peers.
NSKOG is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
NSKOG is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 10
Fwd PE N/A
NSKOG.OL Price Earnings VS Forward Price EarningsNSKOG.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSKOG.OL Per share dataNSKOG.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NSKOG's earnings are expected to grow with 26.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y28.05%
EPS Next 3Y26.11%

2

5. Dividend

5.1 Amount

NSKOG has a Yearly Dividend Yield of 1.65%.
NSKOG's Dividend Yield is comparable with the industry average which is at 3.92.
NSKOG's Dividend Yield is slightly below the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.65%

5.2 History

The dividend of NSKOG decreases each year by -52.50%.
Dividend Growth(5Y)-52.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y28.05%
EPS Next 3Y26.11%
NSKOG.OL Yearly Income VS Free CF VS DividendNSKOG.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B

NORSKE SKOG ASA

OSL:NSKOG (7/11/2025, 7:00:00 PM)

21.9

+0.2 (+0.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-15 2025-07-15
Inst Owners22.02%
Inst Owner ChangeN/A
Ins Owners20.61%
Ins Owner ChangeN/A
Market Cap1.86B
Analysts81.82
Price Target26.52 (21.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.65%
Yearly DividendN/A
Dividend Growth(5Y)-52.5%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-140.93%
Min EPS beat(2)-302.97%
Max EPS beat(2)21.1%
EPS beat(4)2
Avg EPS beat(4)-824.6%
Min EPS beat(4)-3470.39%
Max EPS beat(4)453.85%
EPS beat(8)4
Avg EPS beat(8)302.81%
EPS beat(12)6
Avg EPS beat(12)197%
EPS beat(16)9
Avg EPS beat(16)168.58%
Revenue beat(2)0
Avg Revenue beat(2)-11.37%
Min Revenue beat(2)-21.4%
Max Revenue beat(2)-1.34%
Revenue beat(4)0
Avg Revenue beat(4)-13.5%
Min Revenue beat(4)-21.4%
Max Revenue beat(4)-1.34%
Revenue beat(8)0
Avg Revenue beat(8)-12.51%
Revenue beat(12)1
Avg Revenue beat(12)-10.52%
Revenue beat(16)3
Avg Revenue beat(16)-7.89%
PT rev (1m)0%
PT rev (3m)-10.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-77.66%
EPS NY rev (1m)0%
EPS NY rev (3m)-177.37%
Revenue NQ rev (1m)1.55%
Revenue NQ rev (3m)-7.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.35%
Valuation
Industry RankSector Rank
PE 10
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)2.19
EY10%
EPS(NY)-1.68
Fwd EYN/A
FCF(TTM)-6.42
FCFYN/A
OCF(TTM)-2.04
OCFYN/A
SpS123.89
BVpS66.55
TBVpS66.32
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.75%
ROE -4.46%
ROCE 6.38%
ROIC 5.29%
ROICexc 5.85%
ROICexgc 5.87%
OM 6.68%
PM (TTM) N/A
GM 34.68%
FCFM N/A
ROA(3y)6.63%
ROA(5y)-1.66%
ROE(3y)15.08%
ROE(5y)-4.97%
ROIC(3y)7.92%
ROIC(5y)5.72%
ROICexc(3y)10.51%
ROICexc(5y)7.52%
ROICexgc(3y)10.53%
ROICexgc(5y)7.54%
ROCE(3y)9.55%
ROCE(5y)6.89%
ROICexcg growth 3Y-56.9%
ROICexcg growth 5Y-53.47%
ROICexc growth 3Y-56.85%
ROICexc growth 5Y-53.43%
OM growth 3Y-10.16%
OM growth 5Y-29.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.52%
F-Score2
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.54%
Interest Coverage 13.5
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.86
Altman-Z 0.79
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%323.37%
EPS Next Y92.21%
EPS Next 2Y28.05%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.87%
Revenue growth 3Y-40.12%
Revenue growth 5Y-29.57%
Sales Q2Q%21.56%
Revenue Next Year3.98%
Revenue Next 2Y8.26%
Revenue Next 3Y5.17%
Revenue Next 5YN/A
EBIT growth 1Y-31.11%
EBIT growth 3Y-46.21%
EBIT growth 5Y-50.1%
EBIT Next Year680.85%
EBIT Next 3Y110.48%
EBIT Next 5YN/A
FCF growth 1Y-312.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.6%
OCF growth 3YN/A
OCF growth 5YN/A